Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.
about
Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assaysHepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsImmunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virusQuantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulinsDiagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection.Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.Analysis of the antibody response to an immunodominant epitope of the envelope glycoprotein of a lentivirus and its diagnostic potential.Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based methodAvidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects.What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individualsMaturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.Modification of AxSYM Human Immunodeficiency Virus Assay to Identify Recent Human Immunodeficiency Virus Infections in Korean Human Immunodeficiency Virus-Positive IndividualsLaboratory diagnostics for hepatitis C virus infection.Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses.Detection of hepatitis C virus (HCV) core-specific antibody suggests occult HCV infection among blood donors.Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection.Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype.Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index.Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis.
P2860
Q24645130-3F504D1A-8F67-408C-8D59-FB2DF9E8C422Q26782033-696F98D9-58EA-4315-ADB1-036763218DDBQ27472834-F31F9CAD-23C8-43A1-B272-76B9F792D8DCQ27480975-99107BD8-6310-40D7-8DD5-3BCA9D8AE774Q30426257-67A4A086-34EA-4CD3-B752-ECA50A9100A0Q33785383-7D2C0E2B-830E-431A-806F-D87CD68E13FFQ33999591-7C539F76-1655-4C2B-A1AB-4D0E2F587139Q34058749-201D7FB5-6F75-4245-A85A-B01AFA97BAA8Q34102747-22AE0383-5741-4455-B5CB-03EF8285AABCQ34120470-F5E06274-4163-47CC-A837-0D016FF0E764Q34332284-03EE8C58-4C65-4F31-B947-A91E7B2B51A3Q34431922-F142FCBB-56EE-483A-8D7E-917A220730F2Q34438290-DF31777F-EDD9-4E16-A637-ABBC7DBC435EQ35230133-5248CAA9-5B12-4F31-96D8-31795D74EDE7Q35641144-3E424D1A-CB7D-467B-9DCB-FAB2B993D839Q35869579-37B3B1D2-D18B-4D48-8E80-896CCDB25461Q35883539-C01F5BF6-876C-4EF5-AA11-BBCD4F9DB994Q36000117-5C20AEC1-199D-4EC2-AB85-A8FA0608A8F9Q38020158-015F959A-7E9C-44BF-B380-E9CF3BD0085CQ38195262-2826335D-BE37-4CA1-AC5D-BBCFE6649D7EQ38618790-5D987B3C-ECDA-49DD-89FD-2C346AD93F48Q38866612-048ACFA1-B397-48EB-92EA-6DDA5488351FQ38992041-C689A7B9-9C5A-4D35-B59A-C15C34CB6262Q39880154-0E98B849-ECAA-419F-AE60-803B1F3BE1ECQ40069643-7E6EBCF0-91D1-474B-9943-214135CB9040Q42257049-E4EB2540-E584-45AE-ABFB-6C0353A60201Q43039769-D5DD1471-2957-47EB-A87B-7E41DB11BFF2Q45190964-691B4078-FE04-455F-9790-C7CA6624E15C
P2860
Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Measurement of antibody avidit ...... m passively acquired antibody.
@en
Measurement of antibody avidit ...... m passively acquired antibody.
@nl
type
label
Measurement of antibody avidit ...... m passively acquired antibody.
@en
Measurement of antibody avidit ...... m passively acquired antibody.
@nl
prefLabel
Measurement of antibody avidit ...... m passively acquired antibody.
@en
Measurement of antibody avidit ...... m passively acquired antibody.
@nl
P2093
P356
P1476
Measurement of antibody avidit ...... m passively acquired antibody.
@en
P2093
P304
P356
10.1002/JMV.1890430409
P577
1994-08-01T00:00:00Z